Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for sub-acute radicular leg pain
2023-508537-13-01Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Gabapentin with Placebo (2 arms). Primary endpoint: Change in average leg pain intensity. Started Jan 2025; status: completed.
02
Drugs
gabapentin
Beyond the preview
Go deeper on 2023-508537-13-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508537-13-01.